Surgery Partners, Inc. (NASDAQ:SGRY – Get Free Report) was the target of unusually large options trading activity on Friday. Traders bought 20,755 put options on the stock. This represents an increase of 1,445% compared to the typical daily volume of 1,343 put options.
Wall Street Analysts Forecast Growth
Several research firms have recently weighed in on SGRY. Barclays lowered their price objective on shares of Surgery Partners from $25.00 to $24.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 27th. Macquarie lowered their price objective on shares of Surgery Partners from $34.00 to $33.00 and set an “outperform” rating for the company in a research note on Tuesday, March 11th. Benchmark reiterated a “buy” rating and issued a $35.00 price objective on shares of Surgery Partners in a research note on Monday, April 21st. Finally, Royal Bank Of Canada reiterated an “outperform” rating and issued a $35.00 price objective on shares of Surgery Partners in a research note on Tuesday, March 25th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $33.56.
Check Out Our Latest Stock Report on Surgery Partners
Institutional Inflows and Outflows
Surgery Partners Price Performance
SGRY opened at $19.30 on Friday. The firm has a market cap of $2.47 billion, a P/E ratio of -12.61 and a beta of 1.93. The firm has a 50-day moving average of $22.36 and a 200 day moving average of $22.66. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.73 and a current ratio of 1.89. Surgery Partners has a fifty-two week low of $18.87 and a fifty-two week high of $33.97.
Surgery Partners (NASDAQ:SGRY – Get Free Report) last released its quarterly earnings data on Monday, May 12th. The company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.08 by ($0.04). The business had revenue of $776.00 million for the quarter, compared to analysts’ expectations of $777.77 million. Surgery Partners had a negative net margin of 6.10% and a positive return on equity of 2.41%. Surgery Partners’s revenue for the quarter was up 8.2% compared to the same quarter last year. During the same period last year, the company earned $0.10 earnings per share. On average, research analysts expect that Surgery Partners will post 0.67 EPS for the current year.
Surgery Partners Company Profile
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Featured Articles
- Five stocks we like better than Surgery Partners
- Why Are These Companies Considered Blue Chips?
- New All-Time Highs Coming for Broadcom? Wall Street Says Yes
- What is an Earnings Surprise?
- Overheated Market? Analysts Watch These Red Flags
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 3 Reasons AMD Could Be the Hottest Stock of the Summer
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.